Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05411081 |
|---|---|
| Brief Title: | Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial |
| First Submitted : | June 7, 2022 |
| First Submitted that Met QC Criteria : | June 7, 2022 |
| First Posted : | June 9, 2022 |
| Last Update Submitted that Met QC Criteria : | May 16, 2024 |
| Last Update Posted : | May 20, 2024 (Estimate) |